SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-011416
Filing Date
2021-01-19
Accepted
2021-01-19 16:00:54
Documents
12
Period of Report
2021-01-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d113830d8k.htm   iXBRL 8-K 39881
  Complete submission text file 0001193125-21-011416.txt   167776

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA syrs-20210119.xsd EX-101.SCH 3061
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20210119_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20210119_pre.xml EX-101.PRE 11399
5 EXTRACTED XBRL INSTANCE DOCUMENT d113830d8k_htm.xml XML 3348
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37813 | Film No.: 21535433
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences